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48754 | RSC Adv., 2017, 7, 48754–4875nd structural revision of
a mangrove alkaloid†
Michael T. Green, ‡a Gary R. Peczkowski,‡b Aneesa J. Al-Ani,a
Sophie L. Benjamin, c Nigel S. Simpkins b and Alan M. Jones *d
We report the total synthesis of an alkaloid isolated from the mangrove fungi Hypocrea virens, based on the
originally claimed structure, via a photochemical sequence. Inconsistencies between data sets led to
a revision of the proposed structure followed by a concise synthetic sequence to deliver the revised
natural product.Natural products have served as the source or architectural
inspiration for countless drug discovery eﬀorts. In the eld of
oncology for instance, around half of all nal drug entities were
either natural products or directly derived from them during the
past 70 years.1 This could be due to their pre-validated biolog-
ical relevance and coverage of diﬀerent regions of chemical
space.2 More recently, natural products from the marine world
have been subject to extensive exploration and yielded
compounds that have become clinically approved therapeutics
such as ziconotide and trabectedin.3 Marine derived fungal
metabolites have become an important new avenue of research
in identifying novel structures with potential bioactivity from
spores and cultures.
Connected to our other eﬀorts in medicinal chemistry we
became interested in exploring novel nitrogen based heterocy-
cles as new scaﬀolds.4 Recently, the isolation and spectrall product 1 and a related bioactive
tal Science, Manchester Metropolitan
am, Edgbaston, B15 2TT, UK
am Trent University, NG11 8NS, UK
m, Edgbaston, B15 2TT, UK. E-mail: a.m.
88
ESI) available. CCDC 1569814, 1569815,
a in CIF or other electronic format see
to this work.
8characterisation of the rst naturally occurring example of an
imidazo[1,5-b]isoquinoline-1,3,5(2H)-trione alkaloid (1, Fig. 1)
from the mangrove fungus, Hypocrea virens has been reported
by Hua and co-workers.5 Subsequently, Davies and co-workers
have reported a single example of the related, 7-phenox-
yimidazo[1,5-b]isoquinoline-1,3,5(2H)-trione skeleton (2, Fig. 1)
that exhibits sub-micromolar potency for inhibition of the
proto-oncogene serine/threonine-protein kinase, PIM1 (IC50 ¼
804 nM  37 nM).6Scheme 1 Literature precedent for the reaction of a thiohydantoin
with 2-carboxybenzaldehyde to aﬀord the tricyclic scaﬀold; result of
the analogous hydantoin and 2-carboxybenzaldehyde experiment and
inset selected instructive 1H–13C HMBC correlations and small mole-
cule X-ray crystal structure of 7.
This journal is © The Royal Society of Chemistry 2017
Scheme 2 Two alternative desulfurisation routes to the reported
mangrove alkaloid 1 and single crystal X-ray structure of 1 (inset).
Paper RSC Advances
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View Article OnlineDespite the apparent simplicity of 1, there have been no
conrmatory syntheses reported to date of this mangrove
alkaloid. Intrigued by both the structure of 1 and the recently
reported bioactivity of a related analogue, we pursued
a synthetic campaign to alkaloid 1.
Our initial approach to 1 envisioned a concise route; a double
Knoevenagel and amide bond disconnection to 2-carboxy-
benzaldehyde 3 and 3-methylimidazolidine-2,4-dione 6 (Scheme 1).
6 in turn, could be prepared via a regioselective N3-alkylation of
hydantoin with dimethylacetal dimethylacetamide (DMADMA) in
53% isolated yield.7 The reaction of 2-carboxybenzaldehyde 3 and
a related hydantoin analogue, thiohydantoin 4a has previously been
reported to aﬀord the related heterocyclic scaﬀold 5a (Scheme 1).8Table 1 Comparison of the NMR spectra of isolated 1 and synthetic 1
Isolated material 1 (CDCl3)
No. dH (J in Hz) dC HMBC
1 156.5a
3 156.4a
5 156.5a
5a 136.3
6 8.49, d, 1H (8.2) 117.2 C8, C9a
7 7.63, dd, 1H (8.2, 7.4) 130.2 C9
8 7.48, dd, 1H (7.6, 7.4) 126.9 C6, C9a
9 7.78, d, 1H (7.6) 124.0 C5a, C7, C10
9a 128.7
10 7.71, s, 1H 119.6 C5a, C9a, C1
10a 126.4
NCH3 3.47, s, 3H 27.6 C1, C3
a These dC values were reported to be interchangeable.5
This journal is © The Royal Society of Chemistry 2017However, treatment of 6 with 2-carboxybenzaldehyde 3 failed
to deliver 1, instead an isobenzofuranone derivative 7 was
aﬀorded in 42% isolated yield. The connectivity of 7 was
unambiguously assigned using a 1H–13C HMBC experiment
(Scheme 1, inset).9 Other instructive spectral measurements
included the splitting of the methylene signal in the 1H NMR
spectrum, indicating diastereotopic protons which was
conrmed by 1H–13C HSQC NMR.9 Conclusive evidence for the
structure of 7 was obtained by small molecule X-ray crystallog-
raphy (Scheme 1, inset).10 There are limited reports for the
preparation of this isobenzofuranone derivative.11 In summary,
unusual reactivity of hydantoin gave an unexpected reaction
product compared to thiohydantoin with 2-carbox-
ybenzaldehyde (Scheme 1).12 Attempts to intercept the reaction
pathway via a protecting group strategy or sequentially per-
forming the Knoevenagel step and the amide formation were
also not successful.
We therefore sought to use the tricyclic manifold of 5b as
a rapid entry to 1 via a desulfurisation approach. Stoichiometric
strategies to convert thioamides and thioureas to amides or
ureas, respectively are well known.13 On simple mono-
functionalised thioamides a desulfurisation route using
a photo-redox catalyst has been reported.14 Employing a photo-
synthetic route using Eosin-Y and green LEDs enabled the
modest preparation of 1 but to the best of our knowledge this is
the rst report in a more complex heterocyclic setting (solvent
and UV/vis studies are shown in the ESI).9 Alternatively, a two-
step methylation and hydrolysis route also delivered 1 in an
improved yield (Scheme 2).
To our delight, compound 1 crystallised upon standing in
CDCl3. Small molecule X-ray crystallography (Scheme 2)Synthesised material 1 (CDCl3)
dH (J in Hz) dC HMBC
159.3
149.4
156.9
128.7
8.56, d, 1H (7.5) 129.3 C5, C8, C9a
7.69–7.75, m, 2H 130.4 C9
7.81, ddd, 1H (7.5, 1.5) 134.1 C6, C9a
7.69–7.74, m, 2H 129.1 C7
133.7
0a 7.36, s, 1H 109.1 C1, C5a, C10a
126.8
3.27, s, 3H 24.7 C1, C3
RSC Adv., 2017, 7, 48754–48758 | 48755
Fig. 2 The connectivity pattern of the reported isolated material 1
(shown in black) and the most likely structural isomer 9.
Scheme 3 Synthetic route to the proposed natural product 9 and
small molecule X-ray crystal structure of 9 (inset).
RSC Advances Paper
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View Article Onlineconrmed the preparation of structure 1. However, comparison
of our NMR spectroscopic data with the originally reported5
revealed important disparities (Table 1).
It became obvious by comparison of the NMR spectral data
that the isolated example of 1 diﬀered from that of synthesised
1 (Table 1). In particular, in the 1H NMR spectrum the location
of the C10–H (+0.35 ppm) and N2-methyl group (+0.20 ppm) in
isolated 1 vs. synthesised 1, respectively. Intriguingly, in the
original report5 the amide, urea and arylamide 13C NMRTable 2 Comparison of the isolation data for 1 and the revised structur
Isolated material 1 (CDCl3)
No. dH (J in Hz) dC HMBC
1 156.5
3 156.4
5 156.5
5a 136.3
6 8.49, d, 1H (8.2) 117.2 C8, C9a
7 7.63, dd, 1H (8.2, 7.4) 130.2 C9
8 7.48, dd, 1H (7.6, 7.4) 126.9 C6, C9a
9 7.78, d, 1H (7.6) 124.0 C5a, C7, C10
9a 128.7
10 7.71, s, 1H 119.6 C5a, C9a, C10a
10a 126.4
NCH3 3.47, s, 3H 27.6 C1, C3
48756 | RSC Adv., 2017, 7, 48754–48758spectral carbonyl shis were all reported to be within0.1 ppm,
which would be highly unlikely in the claimed structure.15
Furthermore, our synthesised example of 1 more closely repli-
cates the known ethyl derivative reported by Niopas and Smail,
in particular the location of the C10–H.16 It was therefore shown
by both NMR spectroscopy and conrmation of the small
molecule X-ray crystal structure that the previously isolated
natural product had diﬀerent connectivity. Therefore, taking
account of all of the above it was proposed that the isolated
structure claimed as 1, was in actual fact structural isomer 9
a metabolite of the gliotoxin family (Fig. 2).
Furthermore, other metabolites isolated from Hypocrea
virens and related mangrove fungi include gliotoxin derivatives
demonstrating a potential common biosynthetic pathway.17
Compound 9 is a natural product recently isolated from the
marine fungus Neosartorya pseudoscheri with NMR spectral
data reported in d6-DMSO.18 In order to compare the spectra of 9
with the isolation data associated with the claimed structure of
1, a total synthesis and NMR spectra measurement in CDCl3 was
required (Scheme 3), 9 having previously been prepared only via
degradation studies of gliotoxin with selenium.19 Furthermore,
the proposed structure 9 held promise, as it has also been re-
ported to be found in isolates from Penicillium terlikowskii.20
Esterication of indole 2-carboxylic acid 10 followed by
conversion to the N-methyl amide 12 in water proceeded
smoothly.21 The conversion of 12 to 9 proved more challenging,
with closure of the amine and amide motifs onto a range of
reported oxalyl derivatives giving mixed results.22 The use of
ethyl chlorooxoacetate proved eﬀective via initial formation of
13 (observed in the crude 1H NMR aer 1 h at reux) to aﬀord 9
in 41% isolated yield. Comparison of the 1H and 13C NMR
spectra in CDCl3 revealed that 9 matched the isolation NMRe 9 (both in CDCl3)24
Revised material 9 (CDCl3)
dH (J in Hz) dC HMBC
156.37
156.45
148.8
136.3
8.47, dq, 1H (8.3, 0.9) 117.2 C8, C9a
7.62, ddd, 1H (8.4, 7.3, 1.2) 130.2 C5a, C9
7.47, ddd, 1H (8.2, 7.3, 1.0) 126.9 C6, C9a
7.78, dt, 1H (7.9, 1.0) 124.0 C5a, C7, C10
128.7
7.70, d, 1H (0.8) 119.6 C1, C5a, C9a, C10a
126.4
3.47, s, 3H 27.6 C1, C3
This journal is © The Royal Society of Chemistry 2017
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View Article Onlinedetails for the claimed structure of 1 (Table 2) with some subtle
diﬀerences. The complete structural assignment began from
the C6–H due to the eﬀect of being forced into the deshielding
cone of the peri-carbonyl group (C4).23 The 1H NMR spectral
data was in good accordance between synthesised 9 and iso-
lated 1 with <0.02 ppm diﬀerences for the C6–H and C10–H.
Due to the pulse sequence used further splitting of the aromatic
coupling pattern was observed at the 4J level as expected in
a planar W-coupling system. The reported and observed 1H–13C
HMBC correlations for 9 matched with the isolation data for 1
plus due to the strength of our sample further weak, but in
agreement, correlations were observed (Table 2). Conclusive
evidence for the structure of 9 was obtained by the small
molecule X-ray crystal structure (Scheme 3, inset).10
In summary, we have shown that the originally isolated
natural product 1 through synthesis was gliotoxin derivative 9.
We have reported the rst synthesis, combining a photochem-
ical step of the claimed structure of the mangrove alkaloid 1 and
through structural revision, completed the rst total synthesis
of the revised natural product 9. The reassignment of the
natural product isolated from Hypocrea virens opens the door to
elucidating the biosynthesis or shunt metabolism of gliotoxin
derivatives and provides a new scaﬀold to investigate the
synthesis of gliotoxin family members. The biological evalua-
tion of the reassigned natural product and related family
members will be investigated and reported in due course.
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